Last close As at 06/08/2026
EUR13.09
▲ 0.05 (0.38%)
Market capitalisation
EUR4,001m
Research: Energy & Resources
Despite continued low benchmark refinery margins during H220 due to the impact of COVID-19 on oil products demand, Hellenic Petroleum was able to maintain high production levels and generate substantial positive operating margin thanks to the flexibility of its refining system and increased exports. We anticipate a potentially slower recovery of benchmark margins in 2021 than previously assumed due to continued sluggish demand, at least during H121. However, with Greece looking to prioritise tourism with reduced restrictions on travel, we anticipate this could accelerate a recovery in domestic demand, especially for jet and road fuels. We have updated our estimates and valuation to reflect the Q420 results and peer multiples, and include a contribution from the recently announced 204MW Kozani PV project. Our valuation is unchanged at €6.55/share, representing 13% upside to the current share price.
Hellenic Petroleum |
A flexible refiner in a challenging time |
FY20 results |
Oil & gas |
12 March 2021 |
Share price performance
Business description
Next event
Analyst
Hellenic Petroleum is a research client of Edison Investment Research Limited |
|||||||||||||||||||||||||||||||||||||||||||||
Despite continued low benchmark refinery margins during H220 due to the impact of COVID-19 on oil products demand, Hellenic Petroleum was able to maintain high production levels and generate substantial positive operating margin thanks to the flexibility of its refining system and increased exports. We anticipate a potentially slower recovery of benchmark margins in 2021 than previously assumed due to continued sluggish demand, at least during H121. However, with Greece looking to prioritise tourism with reduced restrictions on travel, we anticipate this could accelerate a recovery in domestic demand, especially for jet and road fuels. We have updated our estimates and valuation to reflect the Q420 results and peer multiples, and include a contribution from the recently announced 204MW Kozani PV project. Our valuation is unchanged at €6.55/share, representing 13% upside to the current share price.
Year-end |
Revenue |
Adjusted EBITDA* (€m) |
Net debt |
P/E |
Dividend yield |
12/19 |
8,857 |
570 |
1,544 |
9.5 |
8.6 |
12/20 |
5,782 |
333 |
1,672 |
N/A |
1.7 |
12/21e |
7,319 |
525 |
1,618 |
12.1 |
4.1 |
12/22e |
7,339 |
634 |
1,443 |
7.5 |
5.4 |
Note: *PBT and EPS are normalised, excluding amortisation of acquired intangibles, exceptional items, and share-based payments.
Higher exports and flexibility boost Q4 results
Hellenic experienced a challenging Q420 as benchmark refining margins remained at record low levels due to continued low demand for global crude oil and oil products. Despite these adversities, Hellenic achieved a better-than-expected operating performance and minimised the impacts of COVID-19. This was possible due to the flexibility of its refining system allowing it to adjust production to changes in demand; increased exports (+14% y-o-y in Q420); and its storage capacity allowing for contango trades. A dividend announcement of €0.10/share for FY20 (subjected to AGM approval), is a signal of the improving outlook for 2021–22.
Chance to benefit from Greece opening for tourists
We expect to see a global recovery of refining margins in 2021, although the pressure from lockdown restrictions is likely to continue for longer than previously anticipated. However, domestic demand in Greece could increase relatively quickly as the country plans to lift a number of restrictions and re-open its tourist sector in May, faster than other countries in Europe. Lifting restrictions and opening the tourist season will lead to an increase in demand both for jet and road fuel, which should result in improving operational and financial performance for Hellenic.
Valuation: Blended valuation of €6.55/share
Our valuation is based on a blend of discounted cash flow (DCF), EV/EBITDA and P/E. Hellenic continues to trade at a premium to European peers (7.3x FY21e EV/EBITDA versus 5.6x, and 12.1x FY21e P/E versus 9.7x) but at a discount to US peers on most metrics. Our blended valuation remains unchanged at €6.55/share.
Benefiting from a high complexity refining system
Hellenic Petroleum operates three refineries in Greece with a total capacity of 344kbd and 65% of the Greek refinery output. It also has sizeable marketing (domestic and international) and petrochemicals divisions. Two of the refineries (Aspropyrgos and Εlefsina) are complex, integrated and provide significant flexibility of feedstocks/throughput. The third, Thessaloniki, is small and simple but houses Hellenic’s petrochemicals units, which have significant Greek and Mediterranean sales and complement Hellenic’s refining system. Hellenic has a large storage capacity (41.8mmbbl) that allowed it to benefit from trading opportunities in H220 (contango trades).
Despite COVID-19, Hellenic’s operations were uninterrupted in 2020. When some refiners in the region curtailed production or terminated activities due to lower demand, Hellenic sourced new customers, including outside Greece, and its exports increased 11% y-o-y in 2020 (+14% in Q420). The company also benefited from the flexibility of the refineries and switched production away from jet fuel (Greek demand for jet fuel dropped 67% y-o-y in 2020 due to the decline in tourism and air traffic) towards other mid-distillate grades. This allowed the refineries to continue operating at a high level and deliver outperformance relative to benchmark margins.
In November, Hellenic successfully completed the full (five-year) maintenance turnaround and upgrade programme for the Aspropyrgos refinery, despite significant challenges due to the pandemic restrictions. It was the largest turnaround project in Hellenic’s history, at a cost of over €130m. In addition to the maintenance work and financial performance uplift, the refinery will also benefit from improved energy efficiencies and a reduction in PM emissions by 50%, reflecting the company’s investment of over €35m in environmental projects.
Progress on renewable energy projects
The company’s increasing commitment to sustainability and environmental improvement projects is seen in its capital investments, with 20% of total capex in FY20 spent in this area and a plan for a corresponding share for FY21 exceeding 35%. This is driving the gradual transition to cleaner forms of energy and improving the environmental footprint of the company’s core business. Hellenic is targeting a 50% reduction in its carbon footprint in the current decade.
The acquisition of a 204MW photovoltaic (PV) project in Kozani, completed in Q420, was a milestone for the implementation of Hellenic’s strategy in Renewable Energy Sources (RES). Hellenic has a target of an overall 600MW installed capacity by 2025, supported by organic growth and acquisitions. The company holds a diversified project portfolio amounting to 1.3GW (PV, wind energy, biomass), in various stages of development (projects and permits).
The construction of the Kozani PV project began in November 2020, with a budget of €130m (€24m deployed in FY20, a further €80–100m in FY21), financed with a €99.9m Eurobond issued in October 2020 (the European Bank for Reconstruction and Development participated at 75% of the issue). The project is expected to be fully operational in Q122 and to generate c 350m kWh of electricity per year. Management expects a stable annual EBITDA of c €17m from 2022 as the previous owner, Juwi, had already secured the purchase price of electricity produced at the facility at 5.73 eurocents per kWh (for 20 years). We include the Kozani project in our valuation model for the first time.
Apart from the Kozani PV project, Hellenic has capacity of 26MW, which is already operational through seven PV parks with a total capacity of 19MW and a wind farm with capacity of 7MW in Pylos in Messinia.
Results: Refining margins up quarter-on-quarter but remain weak
In Q420, Hellenic reported adjusted EBITDA of €77m versus €66m in Q320 and €118m in Q419. FY20 adjusted EBITDA was €333m, down 42% from €572m in FY19. As can be seen in Exhibit 1, the main downturn was in refinery and benchmark margins, followed by the effect of COVID-19 on markets. These combined to a negative impact of €350m. There was also the negative effect of the full turnaround at Aspropyrgos, completed in November.
|
Exhibit 1: Adjusted EBITDA bridge (FY20 vs FY19) |
|
|
Source: Hellenic Petroleum |
Crude oil prices averaged c US$44/bbl in Q420, significantly lower than the Q419 average of c US$63/bbl. This nevertheless represents a recovery from the multi-year lows recorded in Q220, following the OPEC+ countries’ agreement for the control of crude oil production and exports. In Q420 and in early Q121, refining margins recorded a small recovery as inventory started to clear.
|
Exhibit 2: Benchmark margins ($/bbl) for FCC |
Exhibit 3: Benchmark margins ($/bbl) for hydrocracking |
|
|
|
Source: Hellenic Petroleum. Note: FCC = Fluid catalytic cracking. |
Source: Hellenic Petroleum |
|
Exhibit 2: Benchmark margins ($/bbl) for FCC |
|
|
Source: Hellenic Petroleum. Note: FCC = Fluid catalytic cracking. |
|
Exhibit 3: Benchmark margins ($/bbl) for hydrocracking |
|
|
Source: Hellenic Petroleum |
Demand for refinery products in the Greek domestic market was affected mainly by reduced economic activity due to the lockdown in Q420. Demand for transport fuel sharply declined in Q420, affected by the second lockdown (-16% y-o-y). Hellenic still saw a recovery in demand compared to Q220 lows, but it remained materially below 2019 levels, especially in the aviation and bunkering subsectors.
|
Exhibit 4: Domestic market fuel demand (MT 000s) |
Exhibit 5: Aviation and bunkers fuel demand (MT 000s) |
|
|
|
Source: Hellenic Petroleum |
Source: Hellenic Petroleum |
|
Exhibit 4: Domestic market fuel demand (MT 000s) |
|
|
Source: Hellenic Petroleum |
|
Exhibit 5: Aviation and bunkers fuel demand (MT 000s) |
|
|
Source: Hellenic Petroleum |
Currently, the refining sector remains affected by low demand from the lockdown measures; however, the macroeconomic environment should improve in 2021 supported by the vaccine rollout programme. Hellenic should also benefit from Greece reopening to tourists relatively quickly, likely in May, as pandemic restrictions are lifted. This should drive the increase in domestic demand both for jet and road fuel in the region.
Financials: Net debt increases modestly, after accommodating high capex
Hellenic improved its capital structure in FY20, drawing on additional liquidity and reporting end December net debt of €1.7bn compared to €2.1bn at end Q320 and €1.5bn at end FY19. It completed refinancing of €900m credit facilities maturing in Q420/H121, leading to further finance cost reductions of €104m in FY20, down 10% y-oy. Operating cash flow of €450m (€486m in FY19) covered a high level of capital expenditure of €295m in FY20 (€246m in FY19) and dividend payments of €154m. The elevated capex included costs of the Aspropyrgos turnaround, the digital transformation project and the Kozani PV project. We expect a similar level of capex in FY21, which will include €90m investment in the Kozani PV project.
Changes to estimates
Key changes to our financial estimates and market expectations include: weaker global demand for oil products caused by the ongoing COVID-19 pandemic; we have reduced our Q121 refining margin estimate; the adverse impact of a weaker US dollar versus the euro (-4% versus previous forecasts); updated forecast oil prices; and the impact of the Kozani PV project, which we now include in our model for the first time. We have lowered our refining margin estimates for Q121 as most countries have maintained pandemic-related lockdown measures. We expect margins to remain under pressure for at least three to six months, with subsequent improvements starting in the summer tourist season and a gradual recovery of the global economy. Our oil price assumptions, based on the most recent US Energy Information Administration’s forecasts for FY21, are up 29% compared to our November estimates.
All in all, our FY21 total adjusted EBITDA estimate is 8% lower compared to our previous estimate on account of ongoing weakness in the benchmark margins and weaker US dollar (mainly affecting the refining segment), partially offset by higher oil prices (affecting the petrochemicals segment, as oil price drives changes in polypropylene price). Our FY22 total EBITDA includes €18m from RES with the 204MW Kozani PV project expected to be operational in Q122.
Exhibit 6: Changes to Edison forecasts
€m |
Actual |
Edison new |
Edison old |
Difference |
|||
|
FY20 |
FY21e |
FY22e |
FY21e |
FY22e |
FY21e |
FY22e |
Adjusted EBITDA, refining |
187 |
307 |
394 |
362 |
N/A |
-15% |
N/A |
Adjusted EBITDA, petrochemicals |
61 |
107 |
103 |
84 |
N/A |
27% |
N/A |
Adjusted EBITDA, marketing |
97 |
118 |
119 |
134 |
N/A |
-12% |
N/A |
Adjusted EBITDA, RES |
- |
- |
18 |
- |
N/A |
- |
N/A |
Other |
(13) |
(8) |
0 |
(8) |
N/A |
0% |
N/A |
Total Adjusted EBITDA |
333 |
525 |
634 |
573 |
N/A |
-8% |
N/A |
Associates |
30 |
10 |
10 |
10 |
N/A |
-3% |
N/A |
Adjusted EBIT |
85 |
287 |
391 |
331 |
N/A |
-13% |
N/A |
Finance costs |
(115) |
(102) |
(85) |
(107) |
N/A |
-5% |
N/A |
Adjusted net income |
5 |
147 |
237 |
176 |
N/A |
-16% |
N/A |
Source: Hellenic Petroleum data, Edison Investment Research
Valuation
We value Hellenic using a blend of DCF, leveraged and unleveraged FY21e EV/EBITDA and FY21e P/E multiples, arriving at a valuation of €6.55/share, unchanged versus our last published estimate. Changes to our forecasts are shown in Exhibit 6 above.
Hellenic trades on FY21e multiples of 12.1x P/E and 7.3x EV/EBITDA compared to the European group averages of 9.7x and 5.6x, respectively. Its free cash flow (FCF) yield is broadly in line with the peer group average at 10.5% in FY21e and its EV per complexity-adjusted barrel is higher than European peers at $1,471/bod. At the same time, the company trades at a discount to US peers on the majority of valuation metrics.
Our DCF valuation is based on discounted cash flows to 2025, using a 7% cost of capital. We incorporate a terminal value, which assumes the unwinding of working capital and 1% terminal growth. This results in a DCF valuation of €7.00/share versus our previous estimate of €7.13/share. The DCF valuation was positively affected by the addition of the Kozani PV project (€0.10/share) and an increase in oil price assumptions (€0.13/share); however, this was more than offset by the adverse impact of the weaker US dollar versus the euro (-€0.33/share) and a lower refining margins assumption for Q121 (-€0.02/share).
|
Exhibit 7: Hellenic valuation |
|
|
Source: Edison Investment Research, Refinitiv. Note: Priced at 11 March 2021 |
In 2020, the market caps of Hellenic and its peers decreased by an average of c 35%, hitting low points in March and November. Concerns about lower global demand for oil and petrochemicals had a negative impact on global refining systems. Nonetheless, compared to its European peers, Hellenic benefits from a flexible refining system with large storage capacity. Since November, its share price has increased 39%, albeit lagging peers (weighted by bigger companies with operations in the United States), as the market responded favourably to the vaccination programme and higher forecast oil prices.
|
Exhibit 8: Share price performance of Hellenic and its peers since January 2020 |
|
Source: Edison Investment Research, Refinitiv. Note: Priced at 11 March 2021.
Exhibit 9: Peer group valuation table
|
Market cap |
EV |
P/E |
P/E |
EV/EBITDA |
EV/EBITDA |
FCF yield |
FCF yield |
P/CF |
P/CF |
Net debt/ |
Net debt/ |
Div yield |
Refining capacity |
EV/bod of complexity adjusted capacity |
Edison estimate – Hellenic |
1,764 |
3,854 |
12.1 |
7.5 |
7.3 |
6.1 |
10.4% |
20.7% |
3.8 |
3.2 |
3.2 |
2.6 |
4.1% |
344 |
1,471 |
Europe average |
3,011 |
4,694 |
9.7 |
13.6 |
5.6 |
4.7 |
10.5% |
12.5% |
4.3 |
4.0 |
1.4 |
1.2 |
3.5% |
385 |
1,185 |
Grupa Lotos |
2,288 |
2,924 |
12.1 |
7.9 |
5.4 |
3.9 |
5.0% |
11.7% |
5.7 |
4.5 |
1.4 |
1.0 |
1.7% |
211 |
1,253 |
Hellenic Petroleum (consensus) |
2,110 |
4,441 |
10.4 |
8.3 |
7.0 |
6.0 |
18.5% |
21.7% |
3.4 |
3.1 |
3.6 |
3.1 |
7.6% |
344 |
1,520 |
Motor Oil Hellas Corinth Refineries |
1,698 |
2,880 |
9.2 |
6.5 |
6.0 |
4.9 |
4.8% |
13.0% |
4.0 |
5.2 |
0.8 |
0.7 |
7.5% |
185 |
1,290 |
Polski Koncern Naftowy Orlen |
7,646 |
11,478 |
7.1 |
5.9 |
4.1 |
3.7 |
0.4% |
0.7% |
3.2 |
2.8 |
1.3 |
1.2 |
1.2% |
707 |
1,561 |
Saras |
751 |
1,290 |
- |
46.0 |
5.4 |
4.6 |
27.4% |
16.9% |
2.8 |
3.2 |
-0.4 |
-0.4 |
1.6% |
300 |
331 |
Turkiye Petrol Rafinerileri |
3,574 |
5,150 |
9.4 |
7.0 |
5.8 |
5.3 |
6.9% |
11.3% |
6.6 |
5.5 |
1.7 |
1.6 |
1.3% |
564 |
1,156 |
Americas average |
23,825 |
37,999 |
17.0 |
18.3 |
7.9 |
8.2 |
8.2% |
9.7% |
6.8 |
7.2 |
2.2 |
2.3 |
3.3% |
1,789 |
1,475 |
CVR Energy |
2,618 |
3,842 |
20.8 |
28.9 |
7.8 |
10.8 |
9.9% |
9.2% |
6.8 |
8.9 |
2.1 |
2.9 |
0.0% |
185 |
1,222 |
HollyFrontier |
6,703 |
9,038 |
14.1 |
13.2 |
6.6 |
6.4 |
6.8% |
9.8% |
6.7 |
6.5 |
1.3 |
1.3 |
3.4% |
457 |
1,178 |
Marathon Petroleum |
37,774 |
76,964 |
19.7 |
20.2 |
9.1 |
8.3 |
8.9% |
10.5% |
5.7 |
4.9 |
3.7 |
3.4 |
4.0% |
3,021 |
2,111 |
Phillips 66 |
38,332 |
54,250 |
14.0 |
13.8 |
8.6 |
8.3 |
7.1% |
9.6% |
8.1 |
9.5 |
2.1 |
2.0 |
4.3% |
2,184 |
1,876 |
Valero Energy |
33,698 |
45,903 |
16.2 |
15.4 |
7.3 |
7.3 |
8.0% |
9.5% |
6.5 |
6.2 |
1.8 |
1.8 |
4.9% |
3,100 |
987 |
Average |
12,472 |
19,833 |
13.3 |
15.7 |
6.7 |
6.3 |
9.4% |
11.3% |
5.4 |
5.5 |
1.8 |
1.7 |
3.4% |
1,023 |
1,317 |
Source: Edison Investment Research, Refinitiv. Note: Prices as at 11 March 2021. FX = US$1.20/€.
Exhibit 10: Financial summary
IFRS, year-end: 31 December |
€m |
|
2018A |
2019A |
2020A |
2021E |
2022E |
Income statement |
|
|
|
|
|
|
|
Total revenues |
|
|
9,769 |
8,857 |
5,782 |
7,319 |
7,339 |
Cost of sales |
|
|
(8,770) |
(8,052) |
(5,818) |
(6,297) |
(6,449) |
Gross profit |
|
|
999 |
805 |
(36) |
1,022 |
871 |
SG&A (expenses) |
|
|
(475) |
(470) |
(453) |
(453) |
(453) |
Other income/(expense) |
|
|
(10) |
6 |
(13) |
(11) |
(12) |
Exceptionals and adjustments |
|
|
(19) |
2 |
(587) |
271 |
15 |
Reported EBIT |
|
|
514 |
341 |
(501) |
558 |
406 |
Finance income/(expense) |
|
|
(146) |
(151) |
(115) |
(102) |
(85) |
Profit (loss) from JVs / associates (post tax) |
|
|
(2) |
18 |
30 |
10 |
10 |
Other income (includes exceptionals) |
|
|
2 |
(1) |
5 |
0 |
0 |
Reported PBT |
|
|
369 |
207 |
(582) |
466 |
331 |
Income tax expense (includes exceptionals) |
|
|
(154) |
(43) |
185 |
(117) |
(83) |
Reported net income |
|
|
215 |
164 |
(397) |
350 |
248 |
Basic average number of shares, m |
|
|
306 |
306 |
306 |
306 |
306 |
Basic EPS (€) |
|
|
0.7 |
0.5 |
(1.3) |
1.1 |
0.8 |
|
|
|
|
|
|
||
Adjusted EBITDA |
|
|
730 |
570 |
333 |
525 |
634 |
Adjusted EBIT |
|
|
533 |
339 |
85 |
287 |
391 |
Adjusted PBT |
|
|
388 |
205 |
5 |
196 |
316 |
Adjusted net income |
|
|
296 |
185 |
5 |
147 |
237 |
Adjusted EPS (€) |
|
|
0.97 |
0.61 |
0.02 |
0.48 |
0.78 |
DPS (€) |
|
|
0.75 |
0.50 |
0.10 |
0.24 |
0.31 |
|
|
|
|
|
|
||
Balance sheet |
|
|
|
|
|
||
Property, plant and equipment |
|
|
3,269 |
3,298 |
3,380 |
3,418 |
3,365 |
Intangible assets |
|
|
106 |
104 |
106 |
106 |
106 |
Other non-current assets |
|
|
529 |
744 |
797 |
804 |
812 |
Total non-current assets |
|
|
3,903 |
4,146 |
4,283 |
4,328 |
4,283 |
Cash and equivalents |
|
|
1,276 |
1,088 |
1,203 |
808 |
982 |
Inventories |
|
|
993 |
1,013 |
694 |
965 |
980 |
Trade and other receivables |
|
|
822 |
840 |
582 |
533 |
538 |
Other current assets |
|
|
3 |
6 |
12 |
12 |
12 |
Total current assets |
|
|
3,094 |
2,947 |
2,492 |
2,318 |
2,513 |
Non-current loans and borrowings |
|
|
1,627 |
1,610 |
2,131 |
1,681 |
1,681 |
Other non-current liabilities |
|
|
420 |
617 |
465 |
465 |
465 |
Total non-current liabilities |
|
|
2,047 |
2,227 |
2,597 |
2,147 |
2,147 |
Trade and other payables |
|
|
1,349 |
1,402 |
1,547 |
1,549 |
1,560 |
Current loans and borrowings |
|
|
1,109 |
1,022 |
745 |
745 |
745 |
Other current liabilities |
|
|
97 |
115 |
38 |
38 |
38 |
Total current liabilities |
|
|
2,555 |
2,539 |
2,329 |
2,332 |
2,342 |
Equity attributable to company |
|
|
2,331 |
2,262 |
1,786 |
2,106 |
2,244 |
Non-controlling interest |
|
|
64 |
65 |
62 |
62 |
62 |
|
|
|
|
|
|
||
Cashflow statement |
|
|
|
|
|
||
Profit before tax |
|
|
369 |
207 |
(582) |
466 |
331 |
Depreciation and amortisation |
|
|
197 |
231 |
248 |
238 |
243 |
Other adjustments |
|
|
237 |
172 |
233 |
92 |
75 |
Movements in working capital |
|
|
(296) |
26 |
528 |
(219) |
(9) |
Income taxes paid |
|
|
(5) |
(149) |
23 |
(117) |
(83) |
Cash from operations (CFO) |
|
|
503 |
486 |
450 |
460 |
557 |
Capex |
|
|
(157) |
(241) |
(288) |
(276) |
(190) |
Acquisitions & disposals net |
|
|
(16) |
(5) |
(6) |
0 |
0 |
Other investing activities |
|
|
311 |
29 |
17 |
13 |
10 |
Cash used in investing activities (CFIA) |
|
|
138 |
(218) |
(277) |
(263) |
(180) |
Net proceeds from issue of shares |
|
|
(1) |
0 |
0 |
0 |
0 |
Dividends paid in period |
|
|
(151) |
(155) |
(154) |
(31) |
(110) |
Movements in debt |
|
|
(97) |
(111) |
252 |
(450) |
0 |
Other financing activities |
|
|
4 |
(160) |
(144) |
(112) |
(92) |
Cash from financing activities (CFF) |
|
|
(244) |
(458) |
(47) |
(592) |
(202) |
Increase/(decrease) in cash and equivalents |
|
|
397 |
(189) |
125 |
(395) |
175 |
Currency translation differences and other |
|
|
5 |
2 |
(11) |
0 |
0 |
Cash and equivalents at end of period |
|
|
1,275 |
1,088 |
1,203 |
808 |
982 |
Net (debt) cash |
|
|
(1,460) |
(1,544) |
(1,672) |
(1,618) |
(1,443) |
Source: Hellenic Petroleum, Edison Investment Research. Note: Net debt excludes lease liabilities (€0.2bn at end FY20).
|
|
Research: Healthcare
Oasmia is at a major inflection point as it focuses on its transformation into an R&D-driven, specialty pharma company, with commercially available assets. During 2020, with new management at the helm, much progress was made, including the global partnership deal with Elevar Therapeutics for lead oncology asset Apealea (Cremophor-free paclitaxel), and the implementation of significant cost saving programs. Management has kickstarted 2021 with the in-licensing of Cantrixil (in all indications) from Kazia Therapeutics for $4m upfront, the first of ‘a string of pearls’ strategy to bolster the oncology pipeline. Start of the Phase Ib docetaxel micellar trial in prostate cancer, divestment of the animal health business and optimisation of its platform technologies represent value drivers beyond Apealea. Our revised valuation is SEK2.84bn or SEK6.34/share.